<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
82982-055-06
</NDCCode>
<PackageDescription>
6 TABLET, FILM COATED in 1 BOTTLE (82982-055-06)
</PackageDescription>
<NDC11Code>
82982-0055-06
</NDC11Code>
<ProductNDC>
82982-055
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Isentress
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Raltegravir
</NonProprietaryName>
<DosageFormName>
TABLET, FILM COATED
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20230303
</StartMarketingDate>
<EndMarketingDate>
20250930
</EndMarketingDate>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA022145
</ApplicationNumber>
<LabelerName>
Pharmasource Meds, LLC
</LabelerName>
<SubstanceName>
RALTEGRAVIR POTASSIUM
</SubstanceName>
<StrengthNumber>
400
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-10-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20230303
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20250930
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>